The
GAMMASONICS SRP MkII has become a standard for lymphatic mapping in melanoma and breast cancer. This has been proven not only in Australia and New Zealand, but also in Europe and Asia. It is a valuable tool in nuclear medicine and surgery with the identification as defined of
‘any lymph node receiving direct lymphatic drainage from the lesion
site’*. A radioisotope and a colloid are required to perform this type of lymphatic mapping.
The best results have been achieved by utilising Tc-99m and antimony sulphide colloid with relative uniform particles size between
5 and 30 nanometers.
The technique is presently being applied to breast cancer and melanoma, but several groups are trying the technique on bone cancer, thyroid, gynecology and other modalities.
* Professor Roger F. Uren, Medical Center, Royal Prince Alfred Hospital, Sydney, Australia. |
SRP Mk I 1997
|
Gammasonics has been selected as a Finalist in the Year 2000 Australian Technology Awards - Excellence in the Development of Biotechnology and/or Pharmaceutical technology.
Unique Features
* Built in check source 0.9 uCi
* 4 mm effective detection window
* 6 mm CSI(T1) crystal material
* Micro PMT
* Variable sound control and alarm
* Collimator TUNGSTEN material
* Single point calibration facility
* Manual / automatic sampling period
* Foot pedal for resetting the counter
* Power operated by rechargeable battery only for safety to patient
* Automatic switch off when battery charger is connected
* Measurement Range: 20 keV - 364 keV
Gammasonics is currently developing a flexible laparoscopy and intra-cavity imaging probe.
Specifically designed collimators for nuclear medicine are available upon request.
|
